These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12645123)

  • 21. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is glossectomy necessary for late nodal metastases without clinical local recurrence after initial brachytherapy for N0 tongue cancer? A retrospective experience in 111 patients who received salvage therapy for cervical failure.
    Urashima Y; Nakamura K; Kunitake N; Shioyama Y; Sasaki T; Ooga S; Kuratomi Y; Yamamoto T; Kawazu T; Chikui T; Jingu K; Terashima H; Honda H
    Jpn J Clin Oncol; 2006 Jan; 36(1):3-6. PubMed ID: 16418183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Retrospective study of 136 cases of epidermoid carcinoma of the base of the tongue treated at the Alexis Vautrin Centre 1978-1992].
    Hoffstetter S; Malissard L; Pernot M; Luporsi E; Peiffert D; Lapeyre M
    Bull Cancer Radiother; 1996; 83(2):90-6. PubMed ID: 8688225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electroporation therapy for T1 and T2 oral tongue cancer.
    Landström FJ; Nilsson CO; Reizenstein JA; Nordqvist K; Adamsson GB; Löfgren AL
    Acta Otolaryngol; 2011 Jun; 131(6):660-4. PubMed ID: 21190422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Brachytherapy in the management of the initial stage of the mobile tongue carcinoma].
    Bolner A; Campolongo F; Segatta P; Fellin G; Bauer M; Nocini PF
    Acta Otorhinolaryngol Ital; 1999 Apr; 19(2):80-6. PubMed ID: 10434439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose-rate brachytherapy of a single implant with two fractions combined with external beam radiotherapy for hormone-naive prostate cancer.
    Sato M; Mori T; Shirai S; Kishi K; Inagaki T; Hara I
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1002-9. PubMed ID: 18448272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of three major radioactive sources for brachytherapy used in the treatment of node negative T1-T3 oral tongue cancer: influence of age on outcome.
    Yamazaki H; Inoue T; Yoshida K; Yoshioka Y; Furukawa S; Kakimoto N; Shimizutani K
    Anticancer Res; 2007; 27(1B):491-7. PubMed ID: 17348432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Time, dose and volume factors in interstitial brachytherapy combined with external irradiation for oral tongue carcinoma].
    Yorozu A
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Apr; 56(5):303-10. PubMed ID: 8692656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose rate interstitial brachytherapy for stage I-II tongue cancer.
    Umeda M; Komatsubara H; Nishimatsu N; Yokoo S; Shibuya Y; Komori T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Nov; 90(5):667-70. PubMed ID: 11077395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radical radiotherapy compared with surgery for advanced squamous cell carcinoma of the base of tongue.
    van de Pol M; Levendag PC; de Bree RR; Franssen JH; Smeele LE; Nijdam WM; Jansen PP; Meeuwis CA; Leemans CR
    Brachytherapy; 2004; 3(2):78-86. PubMed ID: 15374539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study.
    Polgár C; Major T; Fodor J; Németh G; Orosz Z; Sulyok Z; Udvarhelyi N; Somogyi A; Takácsi-Nagy Z; Lövey K; Agoston P; Kásler M
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1173-81. PubMed ID: 15519789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of early tongue carcinoma with brachytherapy: results over a 25-year period.
    Urashima Y; Nakamura K; Shioyama Y; Nomoto S; Ohga S; Toba T; Yoshitake T; Chikui T; Kawazu T; Jingu K; Terashima H; Honda H
    Anticancer Res; 2007; 27(5B):3519-23. PubMed ID: 17972511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer: optimizing dose escalation.
    Vicini FA; Kestin LL; Martinez AA
    Tech Urol; 2000 Jun; 6(2):135-45. PubMed ID: 10798815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.
    Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose-rate interstitial brachytherapy for mobile tongue cancer: influence of the non-irradiated period.
    Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K
    Anticancer Res; 2006; 26(5B):3933-7. PubMed ID: 17094424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognostic factors for oral tongue carcinoma treated with intra-oral cone electron beam irradiation].
    Hayashi S; Yanagawa S; Kajiura Y; Manabe T; Hoshi H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Apr; 59(5):194-9. PubMed ID: 10361414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late effects of post-high-dose-rate brachytherapy for oropharyngeal carcinoma: are they severer than post-low-dose-rate?
    Nose T; Peiffert D; Lapeyre M; Hoffstetter S; Koizumi M; Nishiyama K
    Strahlenther Onkol; 2004 Dec; 180(12):776-82. PubMed ID: 15592697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer.
    Martin T; Röddiger S; Kurek R; Dannenberg T; Eckart O; Kolotas C; Heyd R; Rogge B; Baltas D; Tunn U; Zamboglou N
    Radiother Oncol; 2004 Apr; 71(1):35-41. PubMed ID: 15066294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.